TEMPS PRESENT aired the investigative report above featuring survivors of blood clots they relate to the use of DRSP (DROSPIRENONE) containing birth control pills.
INVESTIGATIONS OF OCTOBER 2011
INVESTIGATIONS OF OCTOBER 2009
A study funded by FDA has confirmed that DROSPIRENONE (DRSP) containing birth control pills present a 75%-77% higher risk of blood clots than other forms of available birth control. This calls into question the safety profile of the pills for young women, or first time users, as well as other women who are potentially at risk. Blood clots can prove fatal if untreated or undetected. Blood clots can lead to Death, Strokes, CVST, Pulmonary Emboli, Deep Vein Thrombosis, Cardiac Events and complications from the above. Additionally, their long term treatment may require prolonged, or life time use of blood thinners and complications from the originally injury. DRSP (DROSPIRENONE) pills narrowly survived a vote for a ‘market withdrawal’ or ‘recall’. DRSP (DROSPIRENONE) containing birth control pills cannot be said to be the “first choice” for first time users of birth control based upon FDA’s own study.
As illustrated in the October 2009 video above, the sponsor of DRSP Lawsuits has been at the forefront of informing the public about the public health risk posed by DRSP (DROSPIRENONE) birth control pills since 2009 and remains committed to the girls and women that have suffered injuries. More on these pills, as well as a prior ‘recall’ is available at